Effect of sevoflurane preconditioning on ischaemia/reperfusion injury in the rat kidney in vivo

European Journal of Anaesthesiology

Volumn 23, Issue 4, 2006, Pages 319-326

  Obal, D ^a   Dettwiler, S ^a   Favoccia, C ^a   Rascher, K ^b   Preckel, B ^a   Schlack, W ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Anaesthetics inhalational, sevoflurane, preconditioning; Kidney; Rat; Reperfusion injury

Indexed keywords

CREATININE; KETAMINE; SEVOFLURANE;

ANESTHESIA INDUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; HISTOPATHOLOGY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PERFUSION; MALE; MAXIMUM ALLOWABLE CONCENTRATION; NONHUMAN; RANDOMIZATION; RAT; RENAL PROTECTION; REPERFUSION INJURY; SHAM FEEDING; SPECIES COMPARISON; TISSUE SECTION; UNINEPHRECTOMY;

ANIMALS; ISCHEMIC PRECONDITIONING; KIDNEY; MALE; METHYL ETHERS; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 33644813214     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021505002000     Document Type: Article

References (40)

1. Abernethy VE, Lieberthal W. Acute renal failure in the critically ill patient. Crit Care Clin 2002; 18: 203-222.
2. Kashyap VS, Cambria RP, Davison JK, L'Italien GJ. Renal failure after thoracoabdominal aortic surgery. J Vasc Surg 1997; 26: 949-955.
3. Cromheecke S, Meeus R, Nelis A et al. Preservation of myocardial function after coronary surgery with sevoflurane anesthesia: is timing of administration involved? Eur J Anaesthesiol 2004; 21: 49.
4. De Hert SG, ten Broecke PW, Mertens E et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002; 97: 42-49.
5. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100: II340-II344.
6. Bernaudin M, Tang Y, Reilly M, Petit E, Sharp FR. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem 2002; 277: 39 728-39 738.
7. Koti RS, Seifalian AM, Davidson BR. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg 2003; 20: 383-396.
8. Xiong L, Zheng Y, Wu M et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate- regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 2003; 96: 233-237.
9. Toosy N, McMorris EL, Grace PA, Mathie RT. Ischaemic preconditioning protects the rat kidney from reperfusion injury. BJU Int 1999; 84: 489-494.
10. Lee HT, Emala CW. Protein kinase C and G(i/o) proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection. J Am Soc Nephrol 2001; 12: 233-240.
11. Lee HT, Gallos G, Nasr SH, Emala CW. A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2004; 15: 102-111.
12. Behrends M, Walz MK, Kribben A et al. No protection of the porcine kidney by ischaemic preconditioning. Exp Physiol 2000; 85: 819-827.
13. Lee HT, Krichevsky IE, Xu H, Ota-Setlik A, D'Agati VD, Emala CW. Local anesthetics worsen renal function after ischemia-reperfusion injury in rats. Am J Physiol Renal Physiol 2004; 286: F111-F119.
14. Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 2004; 101: 1313-1324.
15. Yamashita J, Ogata M, Itoh M et al. Role of nitric oxide in the renal protective effects of ischemic preconditioning. J Cardiovasc Pharmacol 2003; 42: 419-427.
16. Rampil IJ, Laster MJ, Eger EI. Antagonism of the 5-HT(3) receptor does not alter isoflurane MAC in rats. Anesthesiology 2001; 95: 562-564.
17. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 1983; 35: 198-204.
18. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anaesth 2002; 49: 777-791.
19. Kevin LG, Katz P, Camara AK, Novalija E, Riess ML, Stowe DF. Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts. Anesthesiology 2003; 99: 385-391.
20. Riess ML, Kevin LG, Amadou C, Heisner JS, Stowe DF. Dual exposure to sevoflurane improves anesthetic preconditioning in intact hearts. Anesthesiology 2004; 100: 569-574.
21. Shanley PF, Rosen MD, Brezis M, Silva P, Epstein FH, Rosen S. Topography of focal proximal tubular necrosis after ischemia with reflow in the rat kidney. Am J Pathol 1986; 122: 462-468.
22. Müllenheim J, Fräßdorf J, Preckel B, Thämer V, Schlack W. Ketamine, but not S(+)-ketamine, blocks ischemic preconditioning in rabbit hearts in vivo. Anesthesiology 2001; 94: 630-636.
23. Gobe G, Willgoss D, Hogg N, Schoch E, Endre Z. Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury. Kidney Int 1999; 56: 1299-1304.
24. Glaumann B, Glaumann H, Berezesky IK, Trump BF. Studies on the pathogenesis of ischemic cell injury. II. Morphological changes of the pars convoluta (P1 and P2) of the proximal tubule of the rat kidney made ischemic in vivo. Virchows Arch B Cell Pathol 1975; 19: 281-302.
25. Duffield JS, Park KM, Hsiao LL et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005; 115: 1743-1755.
26. Fujii T, Takaoka M, Tsuruoka N, Kiso Y, Tanaka T, Matsumura Y. Dietary supplementation of L-carnosine prevents ischemia/reperfusion-induced renal injury in rats. Biol Pharm Bull 2005; 28: 361-363.
27. Islam CF, Mathie RT, Dinneen MD, Kiely EA, Peters AM, Grace PA. Ischaemia-reperfusion injury in the rat kidney: The effect of preconditioning. Brit J Urol 1997; 79: 842-847.
28. Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004; 279: 52 282-52 292.
29. Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 1993; 79: 795-807.
30. Lochhead KM, Kharasch ED, Zager RA. Spectrum and subcellular determinants of fluorinated anesthetic-mediated proximal tubular injury. Am J Pathol 1997; 150: 2209-2221.
31. Kharasch ED, Frink Jr EJ, Zager R, Bowdle TA, Artru A, Nogami WM. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 1997; 86: 1238-1253.
32. Cook TL, Beppu WJ, Hitt BA, Kosek JC, Mazze RI. Renal effects and metabolism of sevoflurane in Fisher 344 rats: an in-vivo and in-vitro comparison with methoxyflurane. Anesthesiology 1975; 43: 70-77.
33. Kharasch ED, Thorning D, Garton K, Hankins DC, Kilty CG. Role of renal cysteine conjugate beta-lyase in the mechanism of compound A nephrotoxicity in rats. Anesthesiology 1997; 86: 160-171.
34. Conzen PF, Kharasch ED, Czerner SFA, Artru AA, Reichle FM, Michalowski P et al. Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency. Anesthesiology 2002; 97: 578-584.
35. Mazze RI, Callan CM, Galvez ST, Delgado-Herrera L, Mayer DB. The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: a retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical patients. Anesth Analg 2000; 90: 683-688.
36. Ebert TJ, Frink Jr EJ, Kharasch ED. Absence of biochemical evidence for renal and hepatic dysfunction after 8 h of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology 1998; 88: 601-610.
37. Bito H, Ikeuchi Y, Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology 1997; 86: 1231-1237.
38. Obal D, Preckel B, Scharbatke H et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001; 87: 905-911.
39. Obal D, Scharbatke H, Barthel H, Preckel B, Müllenheim J, Schlack W. Cardioprotection against reperfusion injury is maximal with only two minutes of sevoflurane administration in rats. Can J Anesth 2003; 50: 940-945.
40. Julier K, Da Silva R, Gracia C et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003; 98: 1315-132.